R&D | December 22, 2025
UK to get groundbreaking early detection test for bowel cancer
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
Exploring new opportunities within the fast-growing market of microfluidics
The mobile unit "Breast Health Express" brings advanced medical technology directly to communities in need
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care
Subscribe To Our Newsletter & Stay Updated
